We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
CALL
Advanced Micro Devices
AMD
$747B
| $2.17M | ﹤0.01% |
+14,200
| New | +$2.48M |
|
1302
Devon Energy
DVN
$49.2B
| $2.17M | ﹤0.01% |
+43,267
| New | +$1.92M |
|
1303
Castle Biosciences
CSTL
$743M
| $2.17M | ﹤0.01% |
97,932
+53,032
| +118% | +$1.15M |
|
1304
VanEck BDC Income ETF
BIZD
$1.62B
| $2.16M | ﹤0.01% |
128,040
+66,592
| +108% | +$1.09M |
|
1305
Equity Lifestyle Properties
ELS
$12.9B
| $2.16M | ﹤0.01% |
+33,600
| New | +$2.25M |
|
|
BLEUW
1306
CALL
DELISTED
bleuacacia ltd Warrants
BLEUW
| $2.15M | ﹤0.01% |
200,000
| – | – |
|
1307
Lennox International
LII
$18.8B
| $2.15M | ﹤0.01% |
+4,402
| New | +$2M |
|
1308
Establishment Labs
ESTA
$2.75B
| $2.15M | ﹤0.01% |
42,243
+32,250
| +323% | +$1.29M |
|
|
ILPT
1309
Industrial Logistics Properties Trust
ILPT
$607M
| $2.15M | ﹤0.01% |
500,833
-94,854
| -16% | -$385K |
|
1310
National CineMedia
NCMI
$371M
| $2.13M | ﹤0.01% |
414,386
+150,858
| +57% | +$642K |
|
1311
Fulcrum Therapeutics
FULC
$247M
| $2.13M | ﹤0.01% |
225,573
-279,529
| -55% | -$2.5M |
|
1312
iShares Global 100 ETF
IOO
$8.73B
| $2.13M | ﹤0.01% |
+23,800
| New | +$2.02M |
|
1313
CNO Financial Group
CNO
$5.02B
| $2.12M | ﹤0.01% |
+77,200
| New | +$2.09M |
|
1314
Talkspace
TALK
$876M
| $2.12M | ﹤0.01% |
594,070
+319,736
| +117% | +$869K |
|
|
HCVIW
1315
CALL
DELISTED
Hennessy Capital Investment Corp. VI Warrant
HCVIW
| $2.12M | ﹤0.01% |
201,703
-10,303
| -5% | -$982 |
|
1316
Central Garden & Pet Co Class A
CENTA
$2.46B
| $2.12M | ﹤0.01% |
+57,308
| New | +$2.03M |
|
1317
Pebblebrook Hotel Trust
PEB
$2.17B
| $2.12M | ﹤0.01% |
+137,290
| New | +$2.16M |
|
|
TGNA
1318
DELISTED
TEGNA Inc
TGNA
| $2.11M | ﹤0.01% |
+141,490
| New | +$2.1M |
|
1319
Main Street Capital
MAIN
$5.1B
| $2.11M | ﹤0.01% |
+44,606
| New | +$2.02M |
|
1320
Extreme Networks
EXTR
$3.89B
| $2.11M | ﹤0.01% |
+182,425
| New | +$2.49M |
|
1321
QuidelOrtho
QDEL
$1.15B
| $2.1M | ﹤0.01% |
+43,830
| New | +$2.56M |
|
1322
Core Laboratories
CLB
$502M
| $2.1M | ﹤0.01% |
122,871
+104,510
| +569% | +$1.64M |
|
1323
TeraWulf
WULF
$8.24B
| $2.09M | ﹤0.01% |
796,425
-81,900
| -9% | -$162K |
|
1324
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$12.4B
| $2.09M | ﹤0.01% |
25,500
-46,000
| -64% | -$3.88M |
|
1325
Cognyte Software
CGNT
$659M
| $2.09M | ﹤0.01% |
252,247
-119,455
| -32% | -$847K |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.